We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
Skyworks Solutions
SWKS
$18.7B
| $246K | ﹤0.01% |
+2,506
| New | +$214K |
2015 Q1
0 quarters
|
|
502
Allstate
ALL
$62.7B
| $243K | ﹤0.01% |
3,417
+53
| +2% | +$3.74K |
2013 Q4
5 quarters
|
|
|
SINA
503
DELISTED
Sina Corp
SINA
| $243K | ﹤0.01% |
7,559
+575
| +8% | +$20.7K |
2013 Q4
5 quarters
|
|
504
DELISTED
CHUBB CORPORATION
CB
| $242K | ﹤0.01% |
2,395
-310
| -11% | -$31.4K |
2013 Q2
7 quarters
|
|
505
Target
TGT
$70.1B
| $241K | ﹤0.01% |
2,938
-17
| -0.6% | -$1.31K |
2013 Q2
7 quarters
|
|
506
British American Tobacco
BTI
$129B
| $238K | ﹤0.01% |
4,590
+330
| +8% | +$18.3K |
2014 Q4
1 quarter
|
|
|
HSEA.CL
507
DELISTED
HSBC Holdings plc
HSEA.CL
| $236K | ﹤0.01% |
9,000
| – | – |
2013 Q2
7 quarters
|
|
|
OKS
508
DELISTED
Oneok Partners LP
OKS
| $234K | ﹤0.01% |
5,730
-385
| -6% | -$16.1K |
2014 Q1
4 quarters
|
|
509
Eaton
ETN
$152B
| $232K | ﹤0.01% |
3,411
-200
| -6% | -$13.6K |
2013 Q2
7 quarters
|
|
510
Ares Capital
ARCC
$13.4B
| $231K | ﹤0.01% |
13,481
-5,054
| -27% | -$84.4K |
2014 Q1
4 quarters
|
|
511
Universal Display
OLED
$3.58B
| $231K | ﹤0.01% |
+4,935
| New | +$175K |
2015 Q1
0 quarters
|
|
512
Fortinet
FTNT
$124B
| $228K | ﹤0.01% |
+32,555
| New | +$212K |
2015 Q1
0 quarters
|
|
|
RDS.A
513
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $228K | ﹤0.01% |
4,083
+371
| +10% | +$22K |
2014 Q1
4 quarters
|
|
|
VAR
514
DELISTED
Varian Medical Systems, Inc.
VAR
| $228K | ﹤0.01% |
2,761
+12
| +0.4% | +$963 |
2014 Q4
1 quarter
|
|
515
Sysco
SYY
$40.4B
| $227K | ﹤0.01% |
6,024
+668
| +12% | +$26.3K |
2013 Q2
7 quarters
|
|
516
TE Connectivity
TEL
$61.6B
| $226K | ﹤0.01% |
+3,160
| New | +$217K |
2015 Q1
0 quarters
|
|
517
Omnicell
OMCL
$1.61B
| $222K | ﹤0.01% |
6,333
-1,309
| -17% | -$43.2K |
2014 Q4
1 quarter
|
|
518
Gaming and Leisure Properties
GLPI
$11.4B
| $221K | ﹤0.01% |
+6,000
| New | +$203K |
2015 Q1
0 quarters
|
|
519
Occidental Petroleum
OXY
$62.4B
| $220K | ﹤0.01% |
3,016
-554
| -16% | -$42.8K |
2013 Q3
6 quarters
|
|
520
Workday
WDAY
$46B
| $219K | ﹤0.01% |
2,595
-379
| -13% | -$32K |
2014 Q4
1 quarter
|
|
521
Bausch Health
BHC
$2.36B
| $218K | ﹤0.01% |
+1,100
| New | +$195K |
2015 Q1
0 quarters
|
|
522
ProShares Ultra Financials
UYG
$756M
| $218K | ﹤0.01% |
9,000
| – | – |
2014 Q4
1 quarter
|
|
523
American Express
AXP
$212B
| $215K | ﹤0.01% |
2,755
-1,440
| -34% | -$120K |
2013 Q2
7 quarters
|
|
524
Celldex Therapeutics
CLDX
$2.16B
| $214K | ﹤0.01% |
+512
| New | +$183K |
2015 Q1
0 quarters
|
|
|
GNMK
525
DELISTED
GenMark Diagnostics, Inc
GNMK
| $214K | ﹤0.01% |
16,489
+2,843
| +21% | +$37.2K |
2014 Q4
1 quarter
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.